Arena Pharmaceuticals Inc (NASDAQ:ARNA)
| 92.62 Delayed Data As of Jan 14 |  +0.18 / +0.19%Today’s Change | 45.50 Today|||52-Week Range 94.23 | -0.34% Year-to-Date |
Latest ARNA News | Press Releases
| 5 Reasons Why Pfizer Is a Better Stock to Buy Right Now Than Moderna Jan 13 / MotleyFool.com - Paid Partner Content | 1 Big Question Facing Moderna in 2022 Jan 08 / MotleyFool.com - Paid Partner Content |
| 3 Growth Stocks That Have Generated $179 Billion in Free Cash Flow in 12 Months Jan 12 / MotleyFool.com - Paid Partner Content | Albert Bourla of Pfizer is the CNN Business CEO of the Year Dec 25 / CNN.com |
| 3 No-Brainer Big Pharma Stocks to Buy in 2022 Jan 09 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 92.47 |
| Today’s open | 92.58 |
| Day’s range | 92.33 - 92.78 |
| Volume | 1,375,700 |
| Average volume (3 months) | 994,914 |
| Market cap | $5.7B |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | -192.53% |
| Earnings growth (this year) | -33.36% |
| Earnings growth (next 5 years) | -96.93% |
| Revenue growth (last year) | -99.96% |
| P/E ratio | NM |
| Price/Sales | 13,190.40 |
| Price/Book | 5.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HCMHUTCHMED (China) Ltd | -0.43 | -1.37% |
| PRGOPerrigo Company PLC | +0.11 | +0.28% |
| SRPTSarepta Therapeutics... | -1.29 | -1.78% |
| ---- |
Data as of 4:00pm ET, 01/14/2022
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | -$2.26 |
| Annual revenue (last year) | $319.0K |
| Annual profit (last year) | -$404.7M |
| Net profit margin | -126,875.86% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
